Open Access
MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
Mao Lin
1
,
Xiang-Yang Xue
2
,
Shu-Zhen Liang
1
,
Yinxiong Li
3
,
You-Yong Lv
4
,
Lihua He
1
,
Ke-Cheng Xu
1
,
Lifang Zhang
2
,
Ji-Bing Chen
1
,
Li-Zhi Niu
1
Publication type: Journal Article
Publication date: 2017-04-29
PubMed ID:
28968959
Oncology
Abstract
Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the underlying function of miRNA-187 in cervical cancer remains largely unexplored. In the present study, we demonstrated significantly miRNA-187 down-regulation in cervical cancer tissues and cell lines compared to their normal counterparts. Kaplan-Meier analysis revealed that decreased miRNA-187 was closely associated with shorter overall survival and relapse-free survival. Gain- and loss-of-function studies showed that miRNA-187 suppressed cervical cancer cell proliferation, migration, and invasion, and promoted cervical cancer cell apoptosis. Furthermore, luciferase reporter assay determined that human papillomavirus 16 E6 was a direct functional target of miRNA-187. Taken together, our findings indicate the essential role of miRNA-187 in suppressing cervical cancer progression and indicate a novel link between miRNA-187 and human papillomavirus 16 E6 in cervical cancer.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Oncotarget
1 publication, 5.26%
|
|
|
Bioscience Reports
1 publication, 5.26%
|
|
|
Oncology Letters
1 publication, 5.26%
|
|
|
Infectious Agents and Cancer
1 publication, 5.26%
|
|
|
Cells
1 publication, 5.26%
|
|
|
Journal of Dental Sciences
1 publication, 5.26%
|
|
|
Antiviral Research
1 publication, 5.26%
|
|
|
Archives of Biochemistry and Biophysics
1 publication, 5.26%
|
|
|
Chemico-Biological Interactions
1 publication, 5.26%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 5.26%
|
|
|
Journal of Cellular Biochemistry
1 publication, 5.26%
|
|
|
Journal of Cellular Physiology
1 publication, 5.26%
|
|
|
Neuroscience and Biobehavioral Reviews
1 publication, 5.26%
|
|
|
Bioengineered
1 publication, 5.26%
|
|
|
Cancer Biology and Therapy
1 publication, 5.26%
|
|
|
BioMed Research International
1 publication, 5.26%
|
|
|
Translational Cancer Research
1 publication, 5.26%
|
|
|
Advances in molecular oncology
1 publication, 5.26%
|
|
|
Biomarkers in Medicine
1 publication, 5.26%
|
|
|
1
|
Publishers
|
1
2
3
4
5
|
|
|
Elsevier
5 publications, 26.32%
|
|
|
Taylor & Francis
3 publications, 15.79%
|
|
|
Springer Nature
2 publications, 10.53%
|
|
|
Wiley
2 publications, 10.53%
|
|
|
Impact Journals
1 publication, 5.26%
|
|
|
Spandidos Publications
1 publication, 5.26%
|
|
|
MDPI
1 publication, 5.26%
|
|
|
Association for Dental Sciences of the Republic of China
1 publication, 5.26%
|
|
|
Hindawi Limited
1 publication, 5.26%
|
|
|
AME Publishing Company
1 publication, 5.26%
|
|
|
Publishing House ABV Press
1 publication, 5.26%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
19
Total citations:
19
Citations from 2024:
2
(10.52%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Lin M. et al. MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6 // Oncotarget. 2017. Vol. 8. No. 38. pp. 62914-62926.
GOST all authors (up to 50)
Copy
Lin M., Xue X., Liang S., Li Y., Lv Y., He L., Xu K., Zhang L., Chen J., Niu L. MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6 // Oncotarget. 2017. Vol. 8. No. 38. pp. 62914-62926.
Cite this
RIS
Copy
TY - JOUR
DO - 10.18632/oncotarget.17516
UR - https://doi.org/10.18632/oncotarget.17516
TI - MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
T2 - Oncotarget
AU - Lin, Mao
AU - Xue, Xiang-Yang
AU - Liang, Shu-Zhen
AU - Li, Yinxiong
AU - Lv, You-Yong
AU - He, Lihua
AU - Xu, Ke-Cheng
AU - Zhang, Lifang
AU - Chen, Ji-Bing
AU - Niu, Li-Zhi
PY - 2017
DA - 2017/04/29
PB - Impact Journals
SP - 62914-62926
IS - 38
VL - 8
PMID - 28968959
SN - 1949-2553
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Lin,
author = {Mao Lin and Xiang-Yang Xue and Shu-Zhen Liang and Yinxiong Li and You-Yong Lv and Lihua He and Ke-Cheng Xu and Lifang Zhang and Ji-Bing Chen and Li-Zhi Niu},
title = {MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6},
journal = {Oncotarget},
year = {2017},
volume = {8},
publisher = {Impact Journals},
month = {apr},
url = {https://doi.org/10.18632/oncotarget.17516},
number = {38},
pages = {62914--62926},
doi = {10.18632/oncotarget.17516}
}
Cite this
MLA
Copy
Lin, Mao, et al. “MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.” Oncotarget, vol. 8, no. 38, Apr. 2017, pp. 62914-62926. https://doi.org/10.18632/oncotarget.17516.